Veradermics, Inc. (MANE) saw its stock price soar 5.55% during intraday trading on Tuesday, reflecting strong investor interest in the pharmaceutical company.
The surge follows an analyst upgrade from Citigroup, which raised its price target for Veradermics to $120 from $85. This significant increase in target price suggests growing confidence in the company's growth prospects and future valuation.